Education Center

Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer

Funding for this newsletter series was provided by AstraZeneca

 

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Jennifer Banfield, APRN, FNP

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

Recommended Reading

Asthma in 2016
Clinician Reviews
Chronic Cough
Clinician Reviews
NIAID panel: Introduce peanut foods early to cut allergy risk
Clinician Reviews
Asthma ruled out in 33% of diagnosed adults
Clinician Reviews
Uptick found in severe allergy shot reactions
Clinician Reviews
Many patients’ severe asthma remains uncontrolled
Clinician Reviews
Clearing the Air
Clinician Reviews
Children’s asthma risk reduced with prenatal vitamin D supplementation
Clinician Reviews
Asthma step-up therapy in children improves outcomes
Clinician Reviews
Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs
Clinician Reviews